loader

nasdaq:xcur

LATEST ARTICLES

Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor

Exicure, Inc. Reports Full Year 2025 Financial Results

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

Exicure, Inc. Reports Third Quarter 2025 Financial Results

New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting

Exicure Highlights Recent Achievements and Near-term Strategic Priorities

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Exicure Leads

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES